Pricing Log in Create free account

Relmada Therapeutics, Inc. (RLMD) vs Tectonic Therapeutic, Inc. (TECX)

Relmada Therapeutics, Inc. and Tectonic Therapeutic, Inc. are both Biotechnology companies. Relmada Therapeutics, Inc. and Tectonic Therapeutic, Inc. are of similar size ($402.1M and $379.7M). Across the 8 metrics below, Tectonic Therapeutic, Inc. leads on 5 and Relmada Therapeutics, Inc. on 3.

Valuation

Metric RLMD TECX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.12 1.75 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (24.49%) (22.16%) (32.88%)
Free cash flow yield (29.06%) (18.51%) (23.13%)

Profitability

Metric RLMD TECX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (55.66%) (33.80%) (51.96%)
Return on assets (51.57%) (32.23%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RLMD TECX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 45.28% 40.70% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RLMD TECX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 29.52 22.29 4.97
Net debt to EBITDA 1.57 3.08 1.01

Dividend

Metric RLMD TECX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric RLMD TECX Biotechnology median
Market cap 402.14m 379.65m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack